These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 31527577)

  • 1. Angioplasty or bare metal stent versus drug-eluting endovascular treatment in femoropopliteal artery disease: a systematic review and meta-analysis.
    Varetto G; Gibello L; Boero M; Frola E; Peretti T; Spalla F; Verzini F; Rispoli P
    J Cardiovasc Surg (Torino); 2019 Oct; 60(5):546-556. PubMed ID: 31527577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions.
    Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E
    J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Drug-Eluting Stent with Bare-Metal Stent Implantation in Femoropopliteal Artery Disease: A Systematic Review and Meta-Analysis.
    Ding Y; Zhou M; Wang Y; Cai L; Shi Z
    Ann Vasc Surg; 2018 Jul; 50():96-105. PubMed ID: 29514049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-level and external factors in the use of drug-coated balloons and drug-eluting stents in femoropopliteal endovascular interventions.
    Castro-Dominguez Y; Smolderen KG; Pichert M; Alabi O; Romain G; Huang J; Lee M; Ahmed Z; Peri-Okonny PA; Arham A; Brice A; Chaar CO; Stacy MR; Mena-Hurtado C
    J Vasc Surg; 2022 Dec; 76(6):1675-1680. PubMed ID: 35868423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restenosis Prevention With Drug Eluting or Covered Stents in Femoropopliteal Arterial Occlusive Disease: Evidence From a Comprehensive Network Meta-analysis.
    He R; Ye Y; Li Z; Jiang Y; Li Y; Liu Y; Wang K; Yao C
    Eur J Vasc Endovasc Surg; 2019 Jul; 58(1):61-74. PubMed ID: 31202582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness of Plain Balloon Angioplasty, Bare Metal Stents, Drug-Coated Balloons, and Drug-Eluting Stents for the Treatment of Infrapopliteal Artery Disease: Systematic Review and Bayesian Network Meta-analysis of Randomized Controlled Trials.
    Katsanos K; Kitrou P; Spiliopoulos S; Diamantopoulos A; Karnabatidis D
    J Endovasc Ther; 2016 Dec; 23(6):851-863. PubMed ID: 27708143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.
    Caradu C; Lakhlifi E; Colacchio EC; Midy D; Bérard X; Poirier M; Ducasse E
    J Vasc Surg; 2019 Sep; 70(3):981-995.e10. PubMed ID: 31126769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network meta-analysis of drug-coated balloon angioplasty versus primary nitinol stenting for femoropopliteal atherosclerotic disease.
    Abdoli S; Mert M; Lee WM; Ochoa CJ; Katz SG
    J Vasc Surg; 2021 May; 73(5):1802-1810.e4. PubMed ID: 33249205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany.
    Pietzsch JB; Geisler BP; Garner AM; Zeller T; Jaff MR
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):546-54. PubMed ID: 24782424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Coated Balloon and Drug-Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease.
    Hanna J; Smolderen KG; Castro-Dominguez Y; Romain G; Lee M; Turner J; Mena-Hurtado C
    J Am Heart Assoc; 2023 Apr; 12(7):e028622. PubMed ID: 36974774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions at long-term follow-up: A network meta-analysis of randomized controlled trials.
    Zhou Y; Wang T; He H; Li Q; Wan Z; Lu P; Shu C
    Int J Cardiol; 2024 Jun; 404():131977. PubMed ID: 38508322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).
    Lammer J; Zeller T; Hausegger KA; Schaefer PJ; Gschwendtner M; Mueller-Huelsbeck S; Rand T; Funovics M; Wolf F; Rastan A; Gschwandtner M; Puchner S; Ristl R; Schoder M
    J Am Coll Cardiol; 2013 Oct; 62(15):1320-7. PubMed ID: 23831445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of drug-coated therapies in the superficial femoral artery.
    Sridharan ND; Boitet A; Smith K; Noorbakhsh K; Avgerinos E; Eslami MH; Makaroun M; Chaer R
    J Vasc Surg; 2018 Jan; 67(1):343-352. PubMed ID: 28958476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-Analysis Comparing Endovascular Treatment Modalities for Femoropopliteal Peripheral Artery Disease.
    Khan MS; Zou F; Khan AR; Moustafa A; Schmid CH; Baig M; Hyder ON; Aronow HD
    Am J Cardiol; 2020 Aug; 128():181-188. PubMed ID: 32650917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK.
    Katsanos K; Geisler BP; Garner AM; Zayed H; Cleveland T; Pietzsch JB
    BMJ Open; 2016 May; 6(5):e011245. PubMed ID: 27160845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Endovascular Treatment Modalities for De Novo Femoropopliteal Lesions: A Network Meta-analysis of Randomized Controlled Trials.
    Zhou Y; Zhang Z; Lin S; Xiao J; Ai W; Wang J; Li Y; Li Q
    J Endovasc Ther; 2020 Feb; 27(1):42-59. PubMed ID: 31948375
    [No Abstract]   [Full Text] [Related]  

  • 18. Systematic review and meta-analysis of balloon angioplasty versus primary stenting in the infrapopliteal disease.
    Yang X; Lu X; Ye K; Li X; Qin J; Jiang M
    Vasc Endovascular Surg; 2014 Jan; 48(1):18-26. PubMed ID: 24212407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Approaches to the Management of Advanced Peripheral Artery Disease: Perspectives on Drug-Coated Balloons, Drug-Eluting Stents, and Bioresorbable Scaffolds.
    Zeller T; Rastan A; Macharzina R; Beschorner U; Noory E
    Curr Cardiol Rep; 2015 Sep; 17(9):624. PubMed ID: 26238739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease.
    Bausback Y; Wittig T; Schmidt A; Zeller T; Bosiers M; Peeters P; Brucks S; Lottes AE; Scheinert D; Steiner S
    J Am Coll Cardiol; 2019 Feb; 73(6):667-679. PubMed ID: 30765033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.